Conversely, both GCV and its more lipophilic metabolite could interact with multidrug-resistant proteins (MRPs) in breast cancer cell lines, to inhibit the efflux of other chemotherapeutics [74]. The gene discussed is MRPS7; the disease is breast cancer.